Petrus Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Petrus Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,157	Closed	-$265K	–	642
2023 Q4	$265K	Buy	+5,157	New	+$271K	0.03%	486
2023 Q1	–	Sell	-4,119	Closed	-$296K	–	547
2022 Q4	$296K	Buy	+4,119	New	+$311K	0.04%	272
2019 Q4	–	Sell	-6,793	Closed	-$344K	–	288
2019 Q3	$344K	Sell	6,793 -1,215	-15%	-$57.1K	0.06%	72
2019 Q2	$363K	Sell	8,008 -2,471	-24%	-$115K	0.06%	67
2019 Q1	$500K	Buy	+10,479	New	+$522K	0.1%	50
2017 Q1	–	Sell	-3,926	Closed	-$229K	–	182
2016 Q4	$229K	Buy	+3,926	New	+$215K	0.06%	138

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Petrus Trust Company's BMY Position: Q1 2024 in Review

Petrus Trust Company sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 5,157 shares — an estimated $265K sold.

Petrus Trust Company first reported a position in BMY in Q4 2016 and held it in 6 quarters. The position peaked at $500K in Q1 2019. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Petrus Trust Company reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Petrus Trust Company sold 5,157 Bristol-Myers Squibb shares in Q1 2024, an estimated $265K.
Petrus Trust Company first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 6 quarters.
Petrus Trust Company's Bristol-Myers Squibb position peaked at $500K in Q1 2019.
2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Petrus Trust Company's 13F filing for Q1 2024, filed 15 May 2024.